Join Growin Stock Community!

Concord medical services holdings limitedCCM.US Overview

US StockHealthcare
(No presentation for CCM)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

CCM AI Insights

CCM Overall Performance

CCM AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

CCM Recent Performance

-

Concord medical services holdings limited

0.05%

Avg of Sector

-0.31%

S&P500

CCM PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

CCM Key Information

CCM Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

CCM Profile

Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company operates in two segments, Network and Hospital. Its services include linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, and diagnostic imaging services. The company's other treatments and diagnostic services comprise computed tomography scanners. In addition, it provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, the company offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, it operates specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of December 31, 2021, it operated a network of 16 cooperative centers based in 13 hospitals. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.

Price of CCM

CCM FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

CCM Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-2365.94
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
0.04
PB Ratio
3.00
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
-19.01%
Net Margin
-78.72%
Revenue Growth (YoY)
-7.22%
Profit Growth (YoY)
-2.98%
3-Year Revenue Growth
14.90%
3-Year Profit Growth
11.93%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-2365.94
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
0.04
PB Ratio
3.00
Price-to-FCF
-
Gross Margin
-19.01%
Net Margin
-78.72%
Revenue Growth (YoY)
-7.22%
Profit Growth (YoY)
-2.98%
3-Year Revenue Growth
14.90%
3-Year Profit Growth
11.93%

  • When is CCM's latest earnings report released?

    The most recent financial report for Concord medical services holdings limited (CCM) covers the period of 2024Q2 and was published on 2024/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating CCM's short-term business performance and financial health. For the latest updates on CCM's earnings releases, visit this page regularly.

  • What is the operating profit of CCM?

    According to the latest financial report, Concord medical services holdings limited (CCM) reported an Operating Profit of -98.87M with an Operating Margin of -90.37% this period, representing a decline of 192.39% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is CCM's revenue growth?

    In the latest financial report, Concord medical services holdings limited (CCM) announced revenue of 109.41M, with a Year-Over-Year growth rate of -23.09%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does CCM have?

    As of the end of the reporting period, Concord medical services holdings limited (CCM) had total debt of 3.82B, with a debt ratio of 0.54. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does CCM have?

    At the end of the period, Concord medical services holdings limited (CCM) held Total Cash and Cash Equivalents of 197.61M, accounting for 0.03 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does CCM go with three margins increasing?

    In the latest report, Concord medical services holdings limited (CCM) did not achieve the “three margins increasing” benchmark, with a gross margin of -19.01%%, operating margin of -90.37%%, and net margin of -78.72%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess CCM's profit trajectory and future growth potential.

  • Is CCM's EPS continuing to grow?

    According to the past four quarterly reports, Concord medical services holdings limited (CCM)'s earnings per share (EPS) shows a declining trend, with the latest EPS at -591.6. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.